This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude | Version: 1.0.0 | ||||
| Standards status: Informative | Computable Name: Valueset_cyclosporine_exclude | ||||
Copyright/Legal: (copyright expectations unknown) |
|||||
ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 1093178 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune] |
| 402092 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
| 1093177 | Cyclosporine Ophthalmic Ointment [Optimmune] |
| 402330 | Cyclosporine Ophthalmic Suspension [Restasis] |
| 1093174 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment |
| 351291 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension |
| 1093173 | Cyclosporine Ophthalmic Ointment |
| 378766 | Cyclosporine Ophthalmic Suspension |
| 1156187 | Cyclosporine Ophthalmic Product |
| 1182342 | Optimmune Ophthalmic Product |
| 1182527 | Restasis Ophthalmic Product |
Expansion from tx.fhir.org based on codesystem RxNorm version 03022026
This value set contains 11 concepts